₹1,050.10
+₹3.90 (+0.37%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹468 Cr
P/E
14.25
ROE
17.63%
ROCE
23.20%
About Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)
Founded
1985
CEO
Ashish U Bhuta
Employees
779
HQ
Mumbai, Maharashtra
About Jenburkt Pharmaceuticals Ltd
Jenburkt Pharmaceuticals is in the business of manufacturing, producing, developing and marketing a wide range of branded Pharmaceuticals and health care products. (Source : 202503 Annual Report Page No: 57)
Founded:1985
CEO:Ashish U Bhuta
Employees:779
HQ:Mumbai, Maharashtra
Finished Products
1Sale of Products
₹552.87Cr2Other Operating Revenue
₹1.52CrRaw Materials
1Purchase of stock in Trade
₹86.20Cr2Raw Materials consumed
₹39.76CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹1,074
52W Low
₹1,010
Volume384
Avg VolumeN/A
Beta0.85
Dividend Yield1.95%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
14.25x
Valuation
P/B Ratio
2.37x
Valuation
EPS
₹74.39
Valuation
Dividend Yield
1.95%
Valuation
ROE
17.63%
Profitability
ROCE
23.20%
Profitability
Revenue by Segment
Contribution & growth by business line
Pharmaceutical formulationRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
Local87.4%
Exports12.6%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.01x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
5.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.